Your session is about to expire
← Back to Search
Device
ciPDA for Hearing Loss (ciPDA Trial)
Phase 1
Waitlist Available
Led By Philip Loizou, PhD
Research Sponsored by Philip Loizou
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 weeks
Awards & highlights
ciPDA Trial Summary
The primary purpose of the research is to study how individuals who wear cochlear implants process sounds in noisy environments and also whether newly designed programs can help improve the communicative ability of cochlear implant patients in noisy situations.
Eligible Conditions
- Hearing Loss
ciPDA Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The objective of this study is to assess the safety of the PDA device after long-term use. Safety shall be measured by the adverse events reported in this study and compared to the study results reported in the clinical study for the PMA'd device.
ciPDA Trial Design
1Treatment groups
Experimental Treatment
Group I: ciPDAExperimental Treatment1 Intervention
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Philip LoizouLead Sponsor
Philip Loizou, PhDPrincipal InvestigatorThe University of Texas at Dallas
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger